Firms Navigate Social Media Safely Following Loss Of Facebook Protection
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug industry has options beyond disappearing from Facebook and missing the opportunities the influential networking site offers.
You may also be interested in...
FDA “Progressive Approval” And “Exceptional Approval” Pathways Possible Under Senate Bill
Legislation being drafted by Sen. Kay Hagan, D-N.C., would formalize FDA practices of approving drugs in certain circumstances where the evidence needed for a standard approval cannot be generated.
FDA “Progressive Approval” And “Exceptional Approval” Pathways Possible Under Senate Bill
Legislation being drafted by Sen. Kay Hagan, D-N.C., would formalize FDA practices of approving drugs in certain circumstances where the evidence needed for a standard approval cannot be generated.
The Hunt For Gardasil Adverse Events: A Preview Of Emerging Social Media Challenges
Bachmann-based brouhaha over Merck's human papilloma virus vaccine underscores the liability risks that firms can face as possible risks for their products are discussed more widely.